Status:
UNKNOWN
Clinical Usefulness of Cortisol, Antinuclear Antibodies and High-sensitivity C-reactive Protein in Acute Pancreatitis
Lead Sponsor:
Assiut University
Conditions:
Acute Pancreatitis
Eligibility:
All Genders
18-60 years
Brief Summary
Acute pancreatitis (AP) is a potentially life-threatening disease with varying severity of presentation. Nearly 60%-80% of all cases of AP in developed countries are attributable to either gallstone d...
Detailed Description
Severe acute pancreatitis is one of the most common acute abdomens in clinical practice. Owing to its acute onset, rapid progress, and high mortality, it has become a hot clinical study spot and one o...
Eligibility Criteria
Inclusion
- abdominal pain consistent with AP
- serum amylase activity at least 3 times greater than the upper limit of normal
- Patients of age 18 years or more who are willing to participate in the study and give their consent for same.
Exclusion
- Patients with severe liver disease, pulmonary embolus, sepsis, and renal failure were excluded from the study.
Key Trial Info
Start Date :
February 25 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 30 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03830060
Start Date
February 25 2019
End Date
May 30 2019
Last Update
February 5 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.